| Yttrium-90 DOTATOC: first clinical results A Otte, R Herrmann, A Heppeler, M Behe, E Jermann, P Powell, ... European journal of nuclear medicine 26, 1439-1447, 1999 | 512 | 1999 |
| Radiometal‐labelled macrocyclic chelator‐derivatised somatostatin analogue with superb tumour‐targeting properties and potential for receptor‐mediated internal radiotherapy A Heppeler, S Froidevaux, HR Mäcke, E Jermann, M Béhé, P Powell, ... Chemistry–A European Journal 5 (7), 1974-1981, 1999 | 425 | 1999 |
| High-resolution SPECT using multipinhole collimation NU Schramm, G Ebel, U Engeland, T Schurrat, M Behe, TM Behr IEEE Transactions on Nuclear Science 50 (3), 315-320, 2003 | 375 | 2003 |
| DOTATOC: a powerful new tool for receptor-mediated radionuclide therapy A Otte, E Jermann, M Behe, M Goetze, HC Bucher, HW Roser, A Heppeler, ... European journal of nuclear medicine 24, 792-795, 1997 | 329 | 1997 |
| Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,d-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide … M de Jong, WH Bakker, EP Krenning, WAP Breeman, ME van der Pluijm, ... European journal of nuclear medicine 24, 368-371, 1997 | 305 | 1997 |
| Erythropoietin: a candidate compound for neuroprotection in schizophrenia H Ehrenreich, D Degner, J Meller, M Brines, M Behe, M Hasselblatt, ... Molecular psychiatry 9 (1), 42-54, 2004 | 238 | 2004 |
| [Lys40 (Ahx-DTPA-111In) NH2] exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting D Wild, M Béhé, A Wicki, D Storch, B Waser, M Gotthardt, B Keil, ... Journal of Nuclear Medicine 47 (12), 2025-2033, 2006 | 233 | 2006 |
| Stability of siRNA polyplexes from poly (ethylenimine) and poly (ethylenimine)-g-poly (ethylene glycol) under in vivo conditions: effects on pharmacokinetics and … OM Merkel, D Librizzi, A Pfestroff, T Schurrat, K Buyens, NN Sanders, ... Journal of Controlled Release 138 (2), 148-159, 2009 | 232 | 2009 |
| Fever of unknown origin: prospective comparison of [18F]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET J Meller, G Altenvoerde, U Munzel, A Jauho, M Behe, S Gratz, H Luig, ... European journal of nuclear medicine 27, 1617-1625, 2000 | 224 | 2000 |
| Indication for different mechanisms of kidney uptake of radiolabeled peptides M Gotthardt, J van Eerd-Vismale, WJG Oyen, M De Jong, H Zhang, ... Journal of nuclear medicine 48 (4), 596-601, 2007 | 222 | 2007 |
| 18F-FDG hybrid PET in patients with suspected spondylitis S Gratz, J Dörner, U Fischer, T Behr, M Béhé, G Altenvoerde, J Meller, ... European journal of nuclear medicine and molecular imaging 29, 516-524, 2002 | 212 | 2002 |
| First clinical evidence that imaging with somatostatin receptor antagonists is feasible D Wild, M Fani, M Behe, I Brink, JEF Rivier, JC Reubi, HR Maecke, ... Journal of nuclear Medicine 52 (9), 1412-1417, 2011 | 206 | 2011 |
| Radiolabeled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors TM Behr, N Jenner, M Béhé, C Angerstein The Journal of Nuclear Medicine 40 (6), 1029, 1999 | 203 | 1999 |
| Exendin-4–based radiopharmaceuticals for glucagonlike peptide-1 receptor PET/CT and SPECT/CT D Wild, A Wicki, R Mansi, M Béhé, B Keil, P Bernhardt, G Christofori, ... Journal of Nuclear Medicine 51 (7), 1059-1067, 2010 | 191 | 2010 |
| Cholecystokinin-B/gastrin receptor-targeting peptides for staging and therapy of medullary thyroid cancer and other cholecystokinin-B receptor-expressing malignancies TM Behr, MP Béhé Seminars in nuclear medicine 32 (2), 97-109, 2002 | 189 | 2002 |
| Imaging tumors with peptide-based radioligands TM Behr, M Gotthardt, A Barth, M Behe The Quarterly Journal of Nuclear Medicine and Molecular Imaging 45 (2), 189, 2001 | 184 | 2001 |
| High-linear energy transfer (LET) α versus low-LET β emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi-versus 90Y-labeled … TM Behr, M Béhé, MG Stabin, E Wehrmann, C Apostolidis, R Molinet, ... Cancer research 59 (11), 2635-2643, 1999 | 183 | 1999 |
| Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study E Christ, D Wild, S Ederer, M Béhé, G Nicolas, ME Caplin, M Brändle, ... The lancet Diabetes & endocrinology 1 (2), 115-122, 2013 | 182 | 2013 |
| Trastuzumab and breast cancer. TM Behr, M Behe, B Wormann Massachusetts Medical Soc/nejm, 2001 | 181 | 2001 |
| Detection of somatostatin receptor-positive tumours using the new 99m Tc-tricine-HYNIC-D-Phe 1-Tyr 3-octreotide: first results in patients and comparison with 111 In-DTPA-D-Phe … M Bangard, M Behe, S Guhlke, R Otte, H Bender, HR Maecke, ... European journal of nuclear medicine 27, 628-637, 2000 | 170 | 2000 |
